Company / SG&A per Share
TEVA PHARMACEUTICAL INDUSTRIES LTD SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.15
FY2025
5-year range
$1.01 / $1.15
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
#114 of 210
Health Care
What the data says
At $1.15, TEVA PHARMACEUTICAL INDUSTRIES LTD's sg&a per share ranks #97 of 210 in the Health Care sector. SG&A per Share returned to growth in FY2025 after 2 years of decline, reaching $1.15.
Based on SEC 10-K filings.
1.15 in FY2025 with a 5-year CAGR of +0.0%.
Increased from $1.05 to $1.15 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +2.2%
- 5-Year CAGR
- +0.0%
- 10-Year CAGR
- -
Sector benchmark
#97 of 210 in Health CareTop 46% of 210This company $1.15 Sector average $29.50
▼
-96.1% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 10.0% year-over-year.
- Ranks #114 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2016.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.15 | +10.0% |
| FY2024 | $1.05 | -0.4% |
| FY2023 | $1.05 | -2.6% |
| FY2022 | $1.08 | +7.0% |
| FY2021 | $1.01 | -12.3% |
| FY2020 | $1.15 | -2.1% |
| FY2019 | $1.17 | -100.0% |
| FY2018 | $1350676.38 | +94575172.3% |
| FY2017 | $1.43 | -100.0% |
| FY2016 | $1446409.99 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026